Net Loss Per Share Attributable to Common Stockholders

3 Months Ended

May 31, 2022

Net income (Loss) Per Share Attributable to Common Stockholders

Net income (Loss) Per Share Attributable to Common Stockholders

(11)   Net Loss Per Share Attributable to Common Stockholders

The following table sets forth the computation of basic and diluted net loss per share attributable to Accolade’s common stockholders:

	Three months ended
	May 31,
	2022		2021
Net loss	$	(342,822)	$	(48,707)
Weighted-average common shares used in computing net loss per share		69,738,638		58,261,233
Net loss per share attributable to common stockholders, basic and diluted	$	(4.92)	$	(0.84)

Contingently issuable securities are excluded from diluted net loss per share attributable to common stockholders until the contingency has been resolved. In the periods in which the Company has reported a net loss, the potentially dilutive securities are antidilutive. The following potential outstanding shares of common stock were excluded from the

computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive:

	Three months ended
	May 31,
	2022	2021
Stock options	8,238,444	8,448,011
Unvested restricted stock units	2,579,247	501,952
Shares issued to 2nd.MD employees and subject to vesting	274,224	608,332
Contingent shares in connection with 2nd.MD acquisition	—	1,889,441
Shares issued to PlushCare employees and subject to vesting	831,398	—
Indemnity shares held in escrow in connection with PlushCare acquisition	27,342	—
Shares to be issued to HealthReveal shareholders upon expiration of indemnification	28,089	—
Convertible Senior Notes	5,700,297	5,700,297
Total	17,679,041	17,148,033